Copyright Reports & Markets. All rights reserved.

Global Acute Myeloid Leukemia Therapeutics Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Acute Myeloid Leukemia Therapeutics Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Acute Myeloid Leukemia Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Pipeline Drugs
    • 1.4.3 Chemotherapy Drugs
    • 1.4.4 Chemotherapy Regimens
  • 1.5 Market by Application
    • 1.5.1 Global Acute Myeloid Leukemia Therapeutics Market Share by Application: 2020 VS 2026
    • 1.5.2 Hospitals
    • 1.5.3 Clinics
    • 1.5.4 Home Care
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Acute Myeloid Leukemia Therapeutics Market Perspective (2015-2026)
  • 2.2 Global Acute Myeloid Leukemia Therapeutics Growth Trends by Regions
    • 2.2.1 Acute Myeloid Leukemia Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Acute Myeloid Leukemia Therapeutics Historic Market Share by Regions (2015-2020)
    • 2.2.3 Acute Myeloid Leukemia Therapeutics Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Acute Myeloid Leukemia Therapeutics Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Acute Myeloid Leukemia Therapeutics Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Acute Myeloid Leukemia Therapeutics Players by Market Size
    • 3.1.1 Global Top Acute Myeloid Leukemia Therapeutics Players by Revenue (2015-2020)
    • 3.1.2 Global Acute Myeloid Leukemia Therapeutics Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Acute Myeloid Leukemia Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Acute Myeloid Leukemia Therapeutics Market Concentration Ratio
    • 3.2.1 Global Acute Myeloid Leukemia Therapeutics Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Acute Myeloid Leukemia Therapeutics Revenue in 2019
  • 3.3 Acute Myeloid Leukemia Therapeutics Key Players Head office and Area Served
  • 3.4 Key Players Acute Myeloid Leukemia Therapeutics Product Solution and Service
  • 3.5 Date of Enter into Acute Myeloid Leukemia Therapeutics Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Acute Myeloid Leukemia Therapeutics Historic Market Size by Type (2015-2020)
  • 4.2 Global Acute Myeloid Leukemia Therapeutics Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global Acute Myeloid Leukemia Therapeutics Market Size by Application (2015-2020)
  • 5.2 Global Acute Myeloid Leukemia Therapeutics Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Acute Myeloid Leukemia Therapeutics Market Size (2015-2020)
  • 6.2 Acute Myeloid Leukemia Therapeutics Key Players in North America (2019-2020)
  • 6.3 North America Acute Myeloid Leukemia Therapeutics Market Size by Type (2015-2020)
  • 6.4 North America Acute Myeloid Leukemia Therapeutics Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Acute Myeloid Leukemia Therapeutics Market Size (2015-2020)
  • 7.2 Acute Myeloid Leukemia Therapeutics Key Players in Europe (2019-2020)
  • 7.3 Europe Acute Myeloid Leukemia Therapeutics Market Size by Type (2015-2020)
  • 7.4 Europe Acute Myeloid Leukemia Therapeutics Market Size by Application (2015-2020)

8 China

  • 8.1 China Acute Myeloid Leukemia Therapeutics Market Size (2015-2020)
  • 8.2 Acute Myeloid Leukemia Therapeutics Key Players in China (2019-2020)
  • 8.3 China Acute Myeloid Leukemia Therapeutics Market Size by Type (2015-2020)
  • 8.4 China Acute Myeloid Leukemia Therapeutics Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Acute Myeloid Leukemia Therapeutics Market Size (2015-2020)
  • 9.2 Acute Myeloid Leukemia Therapeutics Key Players in Japan (2019-2020)
  • 9.3 Japan Acute Myeloid Leukemia Therapeutics Market Size by Type (2015-2020)
  • 9.4 Japan Acute Myeloid Leukemia Therapeutics Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Acute Myeloid Leukemia Therapeutics Market Size (2015-2020)
  • 10.2 Acute Myeloid Leukemia Therapeutics Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Acute Myeloid Leukemia Therapeutics Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Acute Myeloid Leukemia Therapeutics Market Size by Application (2015-2020)

11 India

  • 11.1 India Acute Myeloid Leukemia Therapeutics Market Size (2015-2020)
  • 11.2 Acute Myeloid Leukemia Therapeutics Key Players in India (2019-2020)
  • 11.3 India Acute Myeloid Leukemia Therapeutics Market Size by Type (2015-2020)
  • 11.4 India Acute Myeloid Leukemia Therapeutics Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Acute Myeloid Leukemia Therapeutics Market Size (2015-2020)
  • 12.2 Acute Myeloid Leukemia Therapeutics Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Acute Myeloid Leukemia Therapeutics Market Size by Type (2015-2020)
  • 12.4 Central & South America Acute Myeloid Leukemia Therapeutics Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Ambit Biosciences Corporation
    • 13.1.1 Ambit Biosciences Corporation Company Details
    • 13.1.2 Ambit Biosciences Corporation Business Overview
    • 13.1.3 Ambit Biosciences Corporation Acute Myeloid Leukemia Therapeutics Introduction
    • 13.1.4 Ambit Biosciences Corporation Revenue in Acute Myeloid Leukemia Therapeutics Business (2015-2020))
    • 13.1.5 Ambit Biosciences Corporation Recent Development
  • 13.2 Genzyme Corporation Celgene Corporation
    • 13.2.1 Genzyme Corporation Celgene Corporation Company Details
    • 13.2.2 Genzyme Corporation Celgene Corporation Business Overview
    • 13.2.3 Genzyme Corporation Celgene Corporation Acute Myeloid Leukemia Therapeutics Introduction
    • 13.2.4 Genzyme Corporation Celgene Corporation Revenue in Acute Myeloid Leukemia Therapeutics Business (2015-2020)
    • 13.2.5 Genzyme Corporation Celgene Corporation Recent Development
  • 13.3 Clavis Pharma ASA
    • 13.3.1 Clavis Pharma ASA Company Details
    • 13.3.2 Clavis Pharma ASA Business Overview
    • 13.3.3 Clavis Pharma ASA Acute Myeloid Leukemia Therapeutics Introduction
    • 13.3.4 Clavis Pharma ASA Revenue in Acute Myeloid Leukemia Therapeutics Business (2015-2020)
    • 13.3.5 Clavis Pharma ASA Recent Development
  • 13.4 Sunesis Pharmaceuticals
    • 13.4.1 Sunesis Pharmaceuticals Company Details
    • 13.4.2 Sunesis Pharmaceuticals Business Overview
    • 13.4.3 Sunesis Pharmaceuticals Acute Myeloid Leukemia Therapeutics Introduction
    • 13.4.4 Sunesis Pharmaceuticals Revenue in Acute Myeloid Leukemia Therapeutics Business (2015-2020)
    • 13.4.5 Sunesis Pharmaceuticals Recent Development
  • 13.5 Cephalon
    • 13.5.1 Cephalon Company Details
    • 13.5.2 Cephalon Business Overview
    • 13.5.3 Cephalon Acute Myeloid Leukemia Therapeutics Introduction
    • 13.5.4 Cephalon Revenue in Acute Myeloid Leukemia Therapeutics Business (2015-2020)
    • 13.5.5 Cephalon Recent Development
  • 13.6 Bristol-Myers Squibb
    • 13.6.1 Bristol-Myers Squibb Company Details
    • 13.6.2 Bristol-Myers Squibb Business Overview
    • 13.6.3 Bristol-Myers Squibb Acute Myeloid Leukemia Therapeutics Introduction
    • 13.6.4 Bristol-Myers Squibb Revenue in Acute Myeloid Leukemia Therapeutics Business (2015-2020)
    • 13.6.5 Bristol-Myers Squibb Recent Development
  • 13.7 Novartis International AG
    • 13.7.1 Novartis International AG Company Details
    • 13.7.2 Novartis International AG Business Overview
    • 13.7.3 Novartis International AG Acute Myeloid Leukemia Therapeutics Introduction
    • 13.7.4 Novartis International AG Revenue in Acute Myeloid Leukemia Therapeutics Business (2015-2020)
    • 13.7.5 Novartis International AG Recent Development
  • 13.8 GlaxoSmithKline
    • 13.8.1 GlaxoSmithKline Company Details
    • 13.8.2 GlaxoSmithKline Business Overview
    • 13.8.3 GlaxoSmithKline Acute Myeloid Leukemia Therapeutics Introduction
    • 13.8.4 GlaxoSmithKline Revenue in Acute Myeloid Leukemia Therapeutics Business (2015-2020)
    • 13.8.5 GlaxoSmithKline Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Acute Myeloid Leukemia Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Acute Myeloid Leukemia Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    The key players covered in this study
    Ambit Biosciences Corporation
    Genzyme Corporation Celgene Corporation
    Clavis Pharma ASA
    Sunesis Pharmaceuticals
    Cephalon
    Bristol-Myers Squibb
    Novartis International AG
    GlaxoSmithKline

    Market segment by Type, the product can be split into
    Pipeline Drugs
    Chemotherapy Drugs
    Chemotherapy Regimens
    Market segment by Application, split into
    Hospitals
    Clinics
    Home Care

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    Buy now